Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Duchateau · SciRah

Researcher profile · Semantic Scholar

L. Duchateau

Share profile

L. Duchateau — researcher profile on SciRah

h-index: 16
Works: 23
Citations: 11K

Most-cited papers

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.
O. Abe, R. Abe, K. Enomoto, K. Kikuchi +331 more
2005The Lancet7,428 citations
Semantic Scholar
Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.
J. A. van der Hage, C. V. D. van de Velde, J. Julien, M. Tubiana-Hulin +2 more
2001Journal of Clinical Oncology1,108 citations
Semantic Scholar
Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.
N. Bijker, J. Peterse, L. Duchateau, J. Julien +6 more
2001Journal of Clinical Oncology487 citations
Semantic Scholar
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials.
J. Klijn, R. Blamey, F. Boccardo, T. Tominaga +2 more
2001Journal of Clinical Oncology432 citations
Semantic Scholar
Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study.
J. Klijn, L. Beex, L. Mauriac, J. van Zijl +9 more
2000Journal of the National Cancer Institute249 citations Open access
Semantic Scholar
Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer.
R. Paridaens, L. Dirix, Caroline Lohrisch, L. Beex +8 more
2003Annals of Oncology227 citations Open access
Semantic Scholar
Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial.
L. Biganzoli, T. Čufer, P. Bruning, R. Coleman +8 more
2002Journal of Clinical Oncology224 citations Open access
Semantic Scholar
Breast‐conserving therapy for paget disease of the nipple
N. Bijker, E. Rutgers, L. Duchateau, J. Peterse +2 more
2001Cancer82 citations Open access
Semantic Scholar
Improved survival after one course of perioperative chemotherapy in early breast cancer patients. long-term results from the European Organization for Research and Treatment of Cancer (EORTC) Trial 10854.
J. A. van der Hage, C. V. D. van de Velde, J. Julien, J. Floiras +3 more
2001European Journal of Cancer77 citations
Semantic Scholar
Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients. clinical outcomes and oncologists' preferences.
M. Nooij, J. de Haes, L. Beex, J. Wildiers +5 more
2003European Journal of Cancer55 citations
Semantic Scholar
Exemestane (Aromasin) is active and well tolerated as first-line hormonal therapy (HT) of metastatic breast cancer (MBC) patients (pts): results of a randomized phase II trial
R. Paridaens, L. Dirix, L. Beex, M. Nooij +7 more
200047 citations
Semantic Scholar
Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS.
N. Bijker, E. Rutgers, J. Peterse, I. Fentiman +3 more
2001European Journal of Surgical Oncology46 citations
Semantic Scholar
Estimating Number of Events from the Kaplan–Meier Curve for Incorporation in a Literature‐Based Meta‐Analysis: What You Don't See You Can't Get!
L. Duchateau, L. Collette, R. Sylvester, J. Pignon
2000Biometrics35 citations
Semantic Scholar
Doxorubicin‐paclitaxel
L. Biganzoli, T. Čufer, P. Bruning, R. E. Coleman +8 more
2003Cancer34 citations Open access
Semantic Scholar
Treatment outcome studies. pitfalls in current methods and practice.
C. Legrand, R. Sylvester, L. Duchateau, Paul Janssen +1 more
2002European Journal of Cancer19 citations
Semantic Scholar
A new standard treatment for advanced premenopausal breast cancer: A meta-analysis of the Combined Hormonal Agent Trialists Group (CHAT)
J. Klijn, R. W. Blarney, F. Boccardo, T. Tominaga +7 more
199817 citations
Semantic Scholar
Doxorubicin-paclitaxel - A safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European organization for research and treatment of cancer multicenter trial
L. Biganzoli, T. Čufer, P. Bruning, R. Coleman +8 more
200315 citations
Semantic Scholar
AT (doxorubicin-Taxol) versus AC (doxorubicin-cyclophosphamide) as first line chemotherapy in metastatic breast cancer (MBC): A phase III study. (originally presented at ASCO 2000. Abstract 282)
M. Piccart, T. Čufer, P. Bruning, R. Coleman +8 more
200015 citations
Semantic Scholar
Combined treatment with the LHRH-agonist buserelin (LHRH-A) and tamoxifen (TAM) vs single treatment with each drug alone in premenopausal metastatic breast cancer. Final results of EORTC study 10881
J. Klijn, L. Beex, L. Mauriac, J. van Zijl +7 more
199814 citations
Semantic Scholar
Ocriplasmin for Treatment of Vitreomacular Traction and Macular Hole A Systematic Literature Review and Individual Participant Data Meta-Analysis of Randomized, Controlled, Double-Masked Trials.
T. Jackson, J. Haller, K. Blot, L. Duchateau +1 more
2021Survey of ophthalmology11 citations Open access
Semantic Scholar
Breast-conserving therapy for ductal carcinoma in situ Bijker
L. Duchateau
20082 citations
Semantic Scholar
Mammographicc evaluation of adequacy of excision andd detection of local recurrence in breast- conservingg therapy for ductal carcinoma in situ
L. Duchateau
20080 citations
Semantic Scholar
Breast-conserving treatment for ductal carcinoma in situ; analysis of EORTC trial 10853
N. Bijker, J. Peterse, L. Duchateau, J. Julien +6 more
20000 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Piccart×6
Invite
M. Piccart — researcher profile on SciRah
L. Beex×6
Invite
L. Beex — researcher profile on SciRah
L. Biganzoli×6
Invite
L. Biganzoli — researcher profile on SciRah
M. Nooij×5
Invite
M. Nooij — researcher profile on SciRah

×5

Invite

T. Čufer — researcher profile on SciRah

Invite

L. Mauriac — researcher profile on SciRah

Invite

J. Klijn — researcher profile on SciRah

R. Sylvester×4

Invite

R. Sylvester — researcher profile on SciRah

Invite

I. Fentiman — researcher profile on SciRah

Invite

N. Bijker — researcher profile on SciRah

Invite

J. Peterse — researcher profile on SciRah

Invite

J. Julien — researcher profile on SciRah